Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
POLYMER CONJUGATED LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS
Document Type and Number:
WIPO Patent Application WO/2022/152141
Kind Code:
A2
Abstract:
Provided herein are polymer conjugated lipid compounds that can be used in combination with other lipid components, such as cationic lipids, neutral lipids, and cholesterol, to form lipid nanoparticles for delivery of therapeutic agents (e.g., nucleic acid molecules) for therapeutic or prophylactic purposes, including vaccination. Also provided herein are lipid nanoparticle compositions comprising said polymer conjugated lipid compounds.

Inventors:
YING BO (CN)
Application Number:
PCT/CN2022/071492
Publication Date:
July 21, 2022
Filing Date:
January 12, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SUZHOU ABOGEN BIOSCIENCES CO LTD (CN)
International Classes:
A61K47/58; A61K48/00; A61P7/00; C08F120/36; C08F120/38; C08F130/02; C08F220/34
Domestic Patent References:
WO2012067378A22012-05-24
WO2015199952A12015-12-30
WO2016176330A12016-11-03
WO2015011633A12015-01-29
WO2017112865A12017-06-29
WO2008127688A12008-10-23
WO2008016473A22008-02-07
WO2011015347A12011-02-10
WO2007025008A22007-03-01
WO2001055369A12001-08-02
WO2009075886A12009-06-18
WO2012009644A22012-01-19
WO1999024595A11999-05-20
WO2001055371A12001-08-02
WO2013103659A12013-07-11
WO2012019780A12012-02-16
WO2015002667A12015-01-08
WO2013120497A12013-08-22
WO2013120629A12013-08-22
WO2013120500A12013-08-22
WO2013120627A12013-08-22
WO2013120498A12013-08-22
WO2013120626A12013-08-22
WO2013120499A12013-08-22
WO2013120628A12013-08-22
WO2002098443A22002-12-12
WO2003051401A22003-06-26
WO2008052770A22008-05-08
WO2009127230A12009-10-22
WO2006122828A22006-11-23
WO2008083949A22008-07-17
WO2010088927A12010-08-12
WO2010037539A12010-04-08
WO2004004743A12004-01-15
WO2005016376A12005-02-24
WO2006024518A12006-03-09
WO2007095976A22007-08-30
WO2008014979A22008-02-07
WO2008077592A12008-07-03
WO2009030481A12009-03-12
WO2009095226A22009-08-06
WO2011069586A12011-06-16
WO2011026641A12011-03-10
WO2011144358A12011-11-24
WO2012013326A12012-02-02
WO2012089338A12012-07-05
WO2012113513A12012-08-30
WO2012116811A12012-09-07
WO2012116810A12012-09-07
WO2013113502A12013-08-08
WO2013113501A12013-08-08
WO2013113736A12013-08-08
WO2013143698A12013-10-03
WO2013143699A12013-10-03
WO2013143700A22013-10-03
WO2013174409A12013-11-28
WO2014127917A12014-08-28
WO2015024669A12015-02-26
WO2015024668A22015-02-26
WO2015024667A12015-02-26
WO2015024665A12015-02-26
WO2015024666A12015-02-26
WO2015024664A12015-02-26
WO2015101415A12015-07-09
WO2015101414A22015-07-09
WO2015062738A12015-05-07
WO2015101416A12015-07-09
Foreign References:
US8519110B22013-08-27
US7468275B22008-12-23
US20070048776A12007-03-01
US20110124100A12011-05-26
US6310197B12001-10-30
US6849405B22005-02-01
US7456273B22008-11-25
US7183395B22007-02-27
US20090226470A12009-09-10
US20130177581A12013-07-11
US20090093049A12009-04-09
EP2610341A12013-07-03
EP2610340A12013-07-03
Other References:
MUROU ET AL., JOURNAL OF COLLOID AND INTERFACE SCIENCE, vol. 390, 2013, pages 47 - 53
LI ET AL., THERANOSTICS, vol. 5, no. 5, 2015, pages 583 - 596
CAO ET AL., LANGMUIR, vol. 28, 2012, pages 11625 - 11632
SAMBROOK ET AL.: "Molecular Cloning: A Laboratory Manual", 2001
"Current Protocols in Molecular Biology", 2003
BUNDGARD, H.: "Design of Prodrugs", vol. 21-24, 1985, ELSEVIER, pages: 7 - 9
HIGUCHI, T. ET AL.: "Bioreversible Carriers in Drug Design", vol. 14, 1987, AMERICAN PHARMACEUTICAL ASSOCIATION AND PERGAMON
WELLENSIEK ET AL.: "Genome-wide profiling of human cap-independent translation-enhancing elements", NATURE METHODS, vol. 10, no. 8, August 2013 (2013-08-01), pages 747 - 750, XP055658496, DOI: 10.1038/nmeth.2522
CHAPPELL, PNAS, vol. 101, no. 26, 29 June 2004 (2004-06-29), pages 9590 - 9594
PANEK, NUCLEIC ACIDS RESEARCH, vol. 41, 1 September 2013 (2013-09-01), pages 7625 - 7634
"Mol. Biology and Biotechnology: A Comprehensive Desk Reference", 1995
KUBY: "Immunology", 1997
PLIICKTHUNSKERRA, METH. ENZYMOL., vol. 178, 1989, pages 497 - 515
HUSTON ET AL., CELL BIOPHYSICS, vol. 22, 1993, pages 189 - 224
DAY, ADVANCED IMMUNOCHEMISTRY, 1990
"Physician's Desk Reference", 2014
LUNN ET AL., JOURNAL OF POLYMER SCIENCE, PART A: POLYMER CHEMISTRY, vol. 55, 2017, pages 2903 - 2914
SABNIS ET AL.: "A Novel Amino Lipid Series for mRNA Delivery: Improved Endosomal Escape and Sustained Pharmacology and Safety in Non-human Primates", MOLECULAR THERAPY, vol. 26, no. 6, 2018, XP055644778, DOI: 10.1016/j.ymthe.2018.03.010
KORE ET AL., BIOORGANIC & MEDICINAL CHEMISTRY, vol. 21, 2013, pages 4570 - 4574
CHAPPELL ET AL., PROC. NATL. ACAD. SCI. USA, vol. 101, 2004, pages 9590 - 9594
ZHOU ET AL., PROC. NATL. ACAD. SCI., vol. 102, 2005, pages 6273 - 6278
KEDDE ET AL.: "A Pumilio-induced RNA structure switch in p27-3'UTR controls miR-221 and miR-222 accessibility", NAT CELL BIOL., vol. 12, no. 10, October 2010 (2010-10-01), pages 1014 - 20
"Remington's The Science and Practice of Pharmacy", 2006, LIPPINCOTT, WILLIAMS & WILKINS
Attorney, Agent or Firm:
CHINA PATENT AGENT (H.K.) LTD. (CN)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: BRIDGED HETEROCYCLYL-SUBSTITUTED PYRIMIDINE COMPOUNDS, PREPARATION METHOD AND MEDICAL USE THEREOF

Next Patent: GENERATION METHOD FOR VIRTUAL CARD, AND INTERACTION IMPLEMENTATION METHOD AND APPARATUS FOR VIRTUAL ...